Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001140361-16-058644
Filing Date
2016-03-22
Accepted
2016-03-21 20:29:14
Documents
1
Effectiveness Date
2016-03-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 16796
  Complete submission text file 0001140361-16-058644.txt   17980
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: D/A | Act: 33 | File No.: 021-253553 | Film No.: 161519774
SIC: 2834 Pharmaceutical Preparations